TECNOLOGÍA PARA LA MONITORIZACIÓN Y CONTROL DE LA DIABETES

VolverVolver

Resultados 133 resultados LastUpdate Última actualización 15/12/2019 [16:19:00] pdf PDF

Solicitudes publicadas en los últimos 60 días / Applications published in the last 60 days

Página1 de 6 nextPage   por página


SENSOR AND DEVICE FOR LIFETIME IMAGING AND DETECTION APPLICATIONS

NºPublicación: US2019374107A1 12/12/2019

Solicitante:

TESSERACT HEALTH INC [US]

JP_2019512090_A

Resumen de: US2019374107A1

A method of luminance lifetime imaging includes receiving incident photons at an integrated photodetector from luminescent molecules. The incident photons being received through one or more optical components of a point-of-care device. The method also includes detecting arrival times of the incident photons using the integrated photodetector. A method of analyzing blood glucose includes detecting luminance lifetime characteristics of tissue using, at least in part, an integrated circuit that detects arrival times of incident photons from the tissue. The method also includes analyzing blood glucose based upon the luminance lifetime characteristics.

traducir

Catheter Assembly Including Monitoring Capabilities

NºPublicación: US2019374162A1 12/12/2019

Solicitante:

BARD INC C R [US]

JP_2018531674_A

Resumen de: US2019374162A1

A catheter assembly or other elongate tubular device for use in establishing vascular or other access within the body of a patient is disclosed. The catheter assembly is equipped with one or more sensors that enable monitoring of one or more physiological aspects of the patient or physical aspect of the catheter assembly itself when the catheter assembly is disposed within the patient. Such aspects include central venous pressure, body temperature, ECG heart signals, oxygen levels, ultrasound data, glucose, etc. The catheter assembly includes the ability to wirelessly transmit or otherwise forward data relating to the detected physiological parameters to another location, such as a patient electronic medical record, smartphone or other mobile device, nurse station, etc. Catheter assemblies configured to detect the frequency of catheter flushing, flushing quality, etc., are also disclosed.

traducir

THREE-DIMENSIONAL ADHESIVE DEVICE HAVING A MICROELECTRONIC SYSTEM EMBEDDED THEREIN

NºPublicación: US2019374163A1 12/12/2019

Solicitante:

BRAEMAR MFG LLC [US]

US_2014288381_A1

Resumen de: US2019374163A1

A three-dimensional adhesive device to be attached to the body surface of a mammal including a microelectronic sensing system. The system includes (a) a three-dimensional adhesive body made of a pressure sensitive adhesive having an upper surface and a bottom surface; (b) a microelectronic system embedded in the body of the pressure sensitive adhesive; (c) one or more cover layer(s) attached to the upper surface; and (d) optionally a release liner releasably attached to the bottom surface. Suitably the microelectronic system is capable of sensing physical input such as pressure, vibration, sound, electrical activity (e,g. from muscle activity), tension, blood-flow, moisture, temperature, enzyme activity, bacteria, pH, blood sugar, conductivity, resistance, capacitance, inductance or other chemical, biochemical, biological, mechanical or electrical purposes.

traducir

MULTI-STREAM DATA COLLECTION SYSTEM FOR NONINVASIVE MEASUREMENT OF BLOOD CONSTITUENTS

NºPublicación: US2019374135A1 12/12/2019

Solicitante:

MASIMO CORP [US]

US_2019365294_A1

Resumen de: US2019374135A1

The present disclosure relates to noninvasive methods, devices, and systems for measuring various blood constituents or analytes, such as glucose. In an embodiment, a light source comprises LEDs and super-luminescent LEDs. The light source emits light at at least wavelengths of about 1610 nm, about 1640 nm, and about 1665 nm. In an embodiment, the detector comprises a plurality of photodetectors arranged in a special geometry comprising one of a substantially linear substantially equal spaced geometry, a substantially linear substantially non-equal spaced geometry, and a substantially grid geometry.

traducir

Analysis of glucose median, variability, and hypoglycemia risk for therapy guidance

NºPublicación: AU2019268205A1 12/12/2019

Solicitante:

ABBOTT DIABETES CARE INC

US_2019051410_A1

Resumen de: AU2019268205A1

A system and method to provide guidance for diabetes therapy includes determining glycemic risks based on an analysis of glucose data. The analysis includes visualization of a glucose median, the variability of glucose in a patient, and the risk of hypoglycemia. An Advanced Daily Patterns report includes a visualization of an ambulatory glucose profile and a glucose control measure. The glucose control measure provides a highly visible and understandable display of the glucose condition of a patient visually expressed in the categories of low glucose, median glucose and glucose variability.

traducir

ANTI-TNF ANTIBODIES, COMPOSITIONS, METHODS AND USE FOR THE TREATMENT OR PREVENTION OF TYPE 1 DIABETES

NºPublicación: US2019375836A1 12/12/2019

Solicitante:

JANSSEN BIOTECH INC [US]

MX_2018009498_A

Resumen de: US2019375836A1

The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the treatment or prevention of Type I Diabetes (T1D).

traducir

COMPONENT CONCENTRATION MEASUREMENT DEVICE

NºPublicación: WO2019235184A1 12/12/2019

Solicitante:

NIPPON TELEGRAPH & TELEPHONE [JP]

Resumen de: WO2019235184A1

This component concentration measurement device is provided with: a light irradiation unit (101) for irradiating a measurement site (151) with pulsed beam light (121) having a wavelength that is absorbed by glucose; and a detection unit (102) for detecting a photoacoustic signal generated from the measurement site (151) irradiated with the beam light (121) emitted from the light irradiation unit (101). The component concentration measurement device is further provided with: a water content measurement unit (103) for measuring the water content of the skin at the measurement site (151); and a correction unit (104) for correcting the acoustic signal detected by the detection unit (102) using the water content measured by the water content measurement unit (103).

traducir

GLUCOSE SENSING DEVICE

NºPublicación: WO2019234596A1 12/12/2019

Solicitante:

KHALIFA UNIV OF SCIENCE AND TECHNOLOGY [AE]

Resumen de: WO2019234596A1

A glucose sensor includes an insulating metal oxide layer and at least one pair of metallic electrodes arranged on the insulating metal oxide layer and separated by a gap containing the metal oxide layer. In operation, a probe including a voltage supply and current sensor can provide a voltage difference across the first and second metallic electrodes while a sample is present across the gap between the electrodes. A measured current between the first and second metallic electrodes when the voltage difference is provided can be correlated to a glucose level of the sample.

traducir

SYSTEM COORDINATOR AND MODULAR ARCHITECTURE FOR OPEN-LOOP AND CLOSED-LOOP CONTROL OF DIABETES

NºPublicación: US2019374137A1 12/12/2019

Solicitante:

UNIV VIRGINIA PATENT FOUNDATION [US]

CN_102576375_A

Resumen de: US2019374137A1

A structure, method, and computer program product for a diabetes control system provides, but is not limited thereto, the following: open-loop or closed-loop control of diabetes that adapts to individual physiologic characteristics and to the behavioral profile of each person. An exemplary aspect to this adaptation is biosystem (patient or subject) observation and modular control. Consequently, established is the fundamental architecture and the principal components for a modular system, which may include algorithmic observers of patients' behavior and metabolic state, as well as interacting control modules responsible for basal rate, insulin boluses, and hypoglycemia prevention.

traducir

TRANSCUTANEOUS ANALYTE SENSOR

NºPublicación: US2019374104A1 12/12/2019

Solicitante:

DEXCOM INC [US]

US_2019365227_A1

Resumen de: US2019374104A1

The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.

traducir

METHOD, SYSTEM, AND COMPUTER READABLE MEDIUM FOR CONTROLLING INSULIN DELIVERY USING RETROSPECTIVE VIRTUAL BASAL RATES

NºPublicación: EP3576815A1 11/12/2019

Solicitante:

UNIV VIRGINIA PATENT FOUNDATION [US]

CN_110402156_A

Resumen de: WO2018144992A1

Equivalent insulin pump retrospective virtual basal rates for daily injections are constructed from planned insulin injections according to a virtual basal rate profile developed for a patient, and a database of historical insulin injections, i.e. basal injections actually administered by the patient, providing a unified framework for analysis, design, optimization, and adaptation of MDI (multiple daily injections) and CSII (continuous subcutaneous insulin infusion (i.e. insulin pump)) treatment parameters for patients with diabetes.

traducir

SETUP SYNCHRONIZATION APPARATUS AND METHODS FOR END USER MEDICAL DEVICES

NºPublicación: US2019373059A1 05/12/2019

Solicitante:

ASCENSIA DIABETES CARE HOLDINGS AG [CH]

CN_106455980_A

Resumen de: US2019373059A1

Embodiments of the present invention enable setup synchronization of an end user medical device such as a blood glucose meter. Some embodiments may include a controller including a memory; a transceiver operatively coupled to the controller; and a host computer interface operative to couple the controller to a host computer, wherein the memory is operative to store instructions executable on the controller. The instructions are adapted to cause the controller to scan for an advertising medical device using the transceiver, establish a communications connection with a medical device advertising for synchronization, and transmit synchronization data to a medical device once a communication connection has been estabilshed. Numerous other aspects are disclosed.

traducir

SYSTEM FOR DETECTING MALFUNCTIONS IN INSULIN DELIVERY DEVICES

NºPublicación: WO2019229686A1 05/12/2019

Solicitante:

UNIV DEGLI STUDI DI PADOVA [IT]

Resumen de: WO2019229686A1

The present invention involves a system (11) for detecting malfunctions in devices (1) for the administration of insulin, comprising a data processing unit (111) adapted to receive measurements of the glucose concentration from a sensor (21) of glucose monitoring and measurements of the amount of insulin infused by an infusion pump (31), a data input unit (311) operatively connected to the data processing unit (111) and adapted to receive estimates of assumed carbohydrates from a user, a storage unit (211) operatively connected to the data processing unit (111) and adapted to store the glucose concentration measurements, the measurements of the amount of infused insulin, the measurements of the amount of carbohydrates taken; in which the data processing unit (111) is able to calculate the value of a DCOB variable (t) called "weighted glucose variation": in which the data processing unit (111) is further adapted to calculate an ICOB variable (t) named "weighted residual insulin": wherein IOB(t) is the variable which describes the estimate of the residual insulin in the blood over time, γ and δ are two positive constants, and wherein the data processing unit (111) is able to execute at least one anomaly detection algorithm of the unsupervised type configured for assigning an anomaly score to data in a patient data set, based on at least one criterion selected among: - "Density-based"; - "Isolation-based"; - "Statistics-based", and - "hypersurface-based", wherein each patient

traducir

BASAL INSULIN MANAGEMENT

NºPublicación: US2019371461A1 05/12/2019

Solicitante:

INSULET CORP [US]

CA_3048683_A1

Resumen de: US2019371461A1

An improved basal insulin management system and an improved user interface for use therewith are provided. User interfaces are provided that dynamically display basal rate information and corresponding time segment information for a basal insulin program in a graphical format. The graphical presentation of the basal insulin program as it is being built by a user and the graphical presentation of a completed basal insulin program provides insulin management information to the user in a more intuitive and useful format. User interfaces further enable a user to make temporary adjustments to a predefined basal insulin program with the adjustments presented graphically to improve the user's understanding of the changes. As a result of being provided with the user interfaces described herein, users are less likely to make mistakes and are more likely to adjust basal rates more frequently, thereby contributing to better blood glucose control and improved health outcomes.

traducir

TRANSCUTANEOUS ANALYTE SENSOR

NºPublicación: US2019365227A1 05/12/2019

Solicitante:

DEXCOM INC [US]

US_2019374104_A1

Resumen de: US2019365227A1

The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.

traducir

DETERMINING WELLNESS USING ACTIVITY DATA

NºPublicación: US2019365332A1 05/12/2019

Solicitante:

GERO LLC [RU]

WO_2018117914_A1

Resumen de: US2019365332A1

Methods and apparatus comprise a model to accurately assess and track changes in physical activity and locomotor patterns measured by an activity sensor such as accelerometer or step counter of mobile and wearable devices to evaluate the age, hazard rate or hazard ratio, frailty, obesity and type 2 diabetes status. The model is capable of detecting age-related and age-independent hazard rate or hazard ratio and other related parameters such as age, biological age, frailty, obesity and type 2 diabetes status that are detectable in activity sensor data acquired from freely moving subjects engaged in routine activities. The disclosed methods and apparatus have sufficient accuracy for practical implementation in personal and corporate wellness with readily available mobile devices such as personal smartphones and wristbands.

traducir

MULTI-STREAM DATA COLLECTION SYSTEM FOR NONINVASIVE MEASUREMENT OF BLOOD CONSTITUENTS

NºPublicación: US2019365295A1 05/12/2019

Solicitante:

MASIMO CORP [US]

US_2019374135_A1

Resumen de: US2019365295A1

The present disclosure relates to noninvasive methods, devices, and systems for measuring various blood constituents or analytes, such as glucose. In an embodiment, a light source comprises LEDs and super-luminescent LEDs. The light source emits light at at least wavelengths of about 1610 nm, about 1640 nm, and about 1665 nm. In an embodiment, the detector comprises a plurality of photodetectors arranged in a special geometry comprising one of a substantially linear substantially equal spaced geometry, a substantially linear substantially non-equal spaced geometry, and a substantially grid geometry.

traducir

MULTI-STREAM DATA COLLECTION SYSTEM FOR NONINVASIVE MEASUREMENT OF BLOOD CONSTITUENTS

NºPublicación: US2019365294A1 05/12/2019

Solicitante:

MASIMO CORP [US]

US_2019374135_A1

Resumen de: US2019365294A1

The present disclosure relates to noninvasive methods, devices, and systems for measuring various blood constituents or analytes, such as glucose. In an embodiment, a light source comprises LEDs and super-luminescent LEDs. The light source emits light at at least wavelengths of about 1610 nm, about 1640 nm, and about 1665 nm. In an embodiment, the detector comprises a plurality of photodetectors arranged in a special geometry comprising one of a substantially linear substantially equal spaced geometry, a substantially linear substantially non-equal spaced geometry, and a substantially grid geometry.

traducir

METHOD AND DEVICE FOR BLOOD GLUCOSE LEVEL MONITORING

NºPublicación: US2019365301A1 05/12/2019

Solicitante:

SONY MOBILE COMMUNICATIONS INC [JP]

EP_3574830_A1

Resumen de: US2019365301A1

A method for monitoring a blood glucose level of an individual comprises the steps of receiving a first glucose value, which has been measured in a body fluid of the individual other than the individual's blood, the first glucose value representing the blood glucose level of the individual with a first delay; receiving speech of the individual; analyzing the individual's speech; and determining a supplementary glucose value, which represents the blood glucose level of the individual with a shorter delay than the first delay; wherein the determination of the supplementary glucose value is based on the analyzing of the individual's speech. A device and a system for performing the method are also disclosed.

traducir

BLOOD GLUCOSE MANAGEMENT SYSTEM

NºPublicación: US2019365313A1 05/12/2019

Solicitante:

POPS! DIABETES CARE INC [US]

US_2016328527_A1

Resumen de: US2019365313A1

Methods and systems are disclosed for prompting a patient to take a blood glucose management action. A diabetes management application on a mobile device can receive diabetes-related information from the mobile device. The diabetes management application can identify a blood glucose management action prompt based on a comparison of the received diabetes-related information to one or more predetermined prompt criteria. The diabetes management application can generate a blood glucose management action prompt based on the blood glucose management action prompt condition. The diabetes management application can present the blood glucose management action prompt to the patient on a user interface of the mobile device.

traducir

SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM

NºPublicación: US2019365330A1 05/12/2019

Solicitante:

DEXCOM INC [US]

US_2018296164_A1

Resumen de: US2019365330A1

Systems and methods for minimizing or eliminating transient non-glucose related signal noise due to non-glucose rate limiting phenomenon such as ischemia, pH changes, temperatures changes, and the like. The system monitors a data stream from a glucose sensor and detects signal artifacts that have higher amplitude than electronic or diffusion-related system noise. The system replaces some or the entire data stream continually or intermittently including signal estimation methods that particularly address transient signal artifacts. The system is also capable of detecting the severity of the signal artifacts and selectively applying one or more signal estimation algorithm factors responsive to the severity of the signal artifacts, which includes selectively applying distinct sets of parameters to a signal estimation algorithm or selectively applying distinct signal estimation algorithms.

traducir

AUTOMATIC DETECTION OF UN-BOLUSED MEALS

NºPublicación: US2019365997A1 05/12/2019

Solicitante:

TANDEM DIABETES CARE INC [US]

Resumen de: US2019365997A1

Missed meal bolus reminders or alerts require a user to access the user's pump and/or remote control to clear the reminder/alert even when the user skipped a meal such that no meal bolus was needed. CGM data can be leveraged such that the missed meal bolus alert is only triggered when glucose levels rise in response to consuming the meal within the programmed time window. Therefore, the alert is only provided when a meal is actually consumed and no bolus has been delivered. This further allows the user to be alerted sooner, i.e., as soon as glucose levels rise a predetermined amount or passed a predetermined threshold indicating consumption of a meal as opposed to only at the end of the programmed window.

traducir

Apparatus for Optimizing A Patient's Insulin Dosage Regimen

NºPublicación: US2019365996A1 05/12/2019

Solicitante:

HYGIEIA INC [US]

US_2019365995_A1

Resumen de: US2019365996A1

An apparatus for optimizing a patient's insulin dosage regimen over time, comprising: at least a first computer-readable memory for storing data inputs corresponding at least to one or more components in a patient's present insulin dosage regimen and the patient's blood-glucose-level measurements determined at a plurality of times; a processor operatively connected to the at least first computer-readable memory, the processor programmed at least to determine from the data inputs corresponding to the patient's blood-glucose-level measurements determined at a plurality of times whether and by how much to vary at least one of the one or more components of the patient's present insulin dosage regimen in order to maintain the patient's future blood-glucose-level measurements within a predefined range; and a display operative to display information corresponding to at least the patient's present insulin dosage regimen.

traducir

System for Optimizing A Patient's Insulin Dosage Regimen

NºPublicación: US2019365995A1 05/12/2019

Solicitante:

HYGIEIA INC [US]

US_2019365996_A1

Resumen de: US2019365995A1

A system for optimizing a patient's insulin dosage regimen over time, comprising at least a first memory for storing data inputs corresponding at least to one or more components in a patient's present insulin dosage regimen, and data inputs corresponding at least to the patient's blood-glucose-level measurements determined at a plurality of times, and a processor operatively connected to the at least first memory. The processor is programmed at least to determine from the data inputs corresponding to the patient's blood-glucose-level measurements determined at a plurality of times whether and by how much to vary at least one of the one or more components in the patient's present insulin dosage regimen in order to maintain the patient's future blood-glucose-level measurements within a predefined range.

traducir

METHOD AND DEVICE FOR BLOOD GLUCOSE LEVEL MONITORING

Nº publicación: EP3574830A1 04/12/2019

Solicitante:

SONY MOBILE COMMUNICATIONS INC [JP]

US_2019365301_A1

Resumen de: EP3574830A1

A method for monitoring a blood glucose level of an individual comprises the steps of receiving (S1) a first glucose value, which has been measured in a body fluid of the individual other than the individual's blood, the first glucose value representing the blood glucose level of the individual with a first delay; receiving (S6) speech of the individual; analyzing (S7) the individual's speech; and determining (S8) a supplementary glucose value, which represents the blood glucose level of the individual with a shorter delay than the first delay; wherein the determination of the supplementary glucose value is based on the analyzing of the individual's speech. A device and a system for performing the method are also disclosed.

traducir

Página1 de 6 nextPage por página

punteroimgVolver